VETOQUINOL SA |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 94.6 EUR | -1.05% |
|
-5.02% | -7.62% |
| Apr. 30 | Vetoquinol: down after sales update | CF |
| Apr. 29 | Vetoquinol SA Reports Sales Results for the First Quarter of Fiscal 2024 | CI |
Business Summary
- antibiotics;
- anti-inflammatories;
- cardiology and nephrology treatments;
- other: anti-parasitics, vaccines, and nutritional products.
At the end of 2022, the group had 5 production sites throughout the world.
Net sales are distributed geographically as follows: Europe (46.7%), the Americas (36%) and Asia/Pacific (17.3%).
Number of employees: 2,497
Sales per Business
| EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
|---|---|---|---|---|---|
Pets
70.2
%
| 365 | 67.7 % | 372 | 70.2 % | +1.76% |
Livestock
29.8
%
| 174 | 32.3 % | 158 | 29.8 % | -9.72% |
Sales per region
| EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
|---|---|---|---|---|---|
Europe
51.1
%
| 277 | 51.2 % | 270 | 51.1 % | -2.32% |
United States
23.0
%
| - | - | 122 | 23.0 % | - |
Americas excluding United States
14.5
%
| 194 | 36.0 % | 77 | 14.5 % | -60.48% |
Asia/Pacific (Rest of the World)
11.4
%
| 69 | 12.8 % | 61 | 11.4 % | -11.96% |
Managers
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 55 | 01-04-01 | |
| Director of Finance/CFO | 59 | - | |
Philippe Gruet
CTO | Chief Tech/Sci/R&D Officer | - | 21-02-28 |
Sandrine Perrier
CTO | Chief Tech/Sci/R&D Officer | - | 19-10-31 |
| Chief Operating Officer | - | 09-07-31 | |
Étienne Frechin
BRD | Director/Board Member | 86 | 62-07-01 |
Fanny Toillon
IRC | Investor Relations Contact | - | - |
Laurent Thoré
LAW | General Counsel | - | - |
| Corporate Officer/Principal | 67 | 13-09-01 | |
Alain Masson
PRN | Corporate Officer/Principal | 62 | 08-04-03 |
Members of the board
| Members of the board | Title | Age | Since |
|---|---|---|---|
Étienne Frechin
BRD | Director/Board Member | 86 | 62-07-01 |
| Chief Executive Officer | 55 | 01-04-01 | |
Philippe Arnold
BRD | Director/Board Member | 83 | 07-06-03 |
Louis Champel
BRD | Director/Board Member | 80 | 09-08-26 |
Luc Frechin
BRD | Director/Board Member | 51 | 21-04-30 |
| Director/Board Member | 75 | 13-05-21 | |
| Director/Board Member | 63 | - | |
Audrey Chanoinat
BRD | Director/Board Member | - | 21-12-05 |
Share class
| Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
|---|---|---|---|---|---|
| Stock A | 1 | 11,881,902 | 3,871,449 ( 32.58 %) | 47,740 ( 0.4018 %) | 32.58 % |
Holdings
| Name | Equities | % | Valuation |
|---|---|---|---|
VETOQUINOL SA 0.42% | 49,903 | 0.42% | 5,362,576 $ |
Company contact information
Vétoquinol SA
34, rue du Chêne Sainte-Anne Magny-Vernois
70200, Lure
+33 3 84 62 55 55
http://www.vetoquinol.com
Group companies
| Name | Category and Sector |
|---|---|
Vetoquinol International
 Vetoquinol International Financial ConglomeratesFinance Part of Vetoquinol SA, Vetoquinol International is an investment holding French company. The private company is based in Lure, France and was founded in 2008. |
Financial Conglomerates
|
Sector
Sales per Business
Sales per region
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
HOLD
Number of Analysts
6
Last Close Price
94.6
EUR
Average target price
105.7
EUR
Spread / Average Target
+11.70%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -7.62% | 1.21B | |
| -9.19% | 6.67B | |
| +24.75% | 3.7B | |
| -1.11% | 3.21B | |
| +6.08% | 1.52B | |
| -15.13% | 1.37B | |
| -25.63% | 1.24B | |
| -10.84% | 1.17B | |
| -.--% | 1.05B | |
| -7.07% | 832M |
- Stock Market
- Equities
- VETO Stock
- Company Vetoquinol SA
